Universe Pharmaceuticals Inc. logo

Universe Pharmaceuticals Inc.

UPC | NASDAQ
Chart Builder DCF Calculator
$4.67
+$0.03 (+0.65%)
At close: Sep 22, 2026, 4:00 PM ET
$4.66
-$0.01 (-0.21%)
After-hours: Sep 22, 2026, 6:56 PM ET

Company Profile

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.

Key Executives

Name Position
Gang Lai Chief Executive Officer & Chairman
Baochang Liu Chief Operating Officer
Lin Yang Chief Financial Officer & Director
Universe Pharmaceuticals Inc.
Universe Pharmaceuticals Inc. logo
Country China
IPO Date Mar 22, 2021
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 216
CEO Gang Lai

Contact Details

No. 265, Jingjiu Avenue Ji'An, JX 343100 China

Stock Details

Ticker Symbol UPC
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001809616
CUSIP Number G9442G138
ISIN Number KYG9442G1385
SIC Code 2834

© 2026 bestshares.com. All rights reserved.